T1	Disease 73 76	AML
#1	AnnotatorNotes T1	DOID:9119
T12	Disease 954 959	e‐AML
T14	Disease 963 968	s‐AML
T16	Biomarker 993 1071	significant genetic alterations such as TP53, TET2, ASXL1, and RUNX1 mutations
T18	Disease 1202 1207	e‐AML
T19	Biomarker 1222 1299	mutations concerning PTPN11, NPM1, RUNX1, ASXL1, TET2, DNMT3A, and TP53 genes
T2	Disease 174 177	AML
T20	Biomarker 1342 1367	DNMT3A and TP53 mutations
T22	Disease 1558 1563	e‐AML
T24	Disease 1670 1675	S‐AML
T25	Biomarker 1713 1727	NPM1 mutations
T27	Disease 1771 1800	AML secondary to MDS and CMML
T3	Biomarker 233 263	TP53, RUNX1, ASXL1 aberrations
T30	Biomarker 1814 1838	ASXL1 and NRAS mutations
T32	Disease 2060 2067	e/s‐AML
T4	Biomarker 349 366	biCEBPA mutations
T8	Biomarker 717 733	DNMT3A mutations
T9	Biomarker 800 815	biallelic CEBPA
T34	Gene-Protein 233 237	TP53
T35	Gene-Protein 239 244	RUNX1
T36	Gene-Protein 223 227	FLT3
T37	Gene-Protein 246 251	ASXL1
T38	Gene-Protein 269 274	KMT2A
T39	Gene-Protein 368 373	RUNX1
T40	Gene-Protein 374 382	RUNXT1T1
T41	Gene-Protein 393 398	MYH11
T42	Gene-Protein 388 392	CBFβ
T43	Gene-Protein 349 356	biCEBPA
T44	Disease 567 574	e/s‐AML
T5	Biomarker 223 231	FLT3‐ITD
T6	Biomarker 368 382	RUNX1‐RUNXT1T1
T7	Biomarker 269 289	KMT2A rearrangements
T45	Biomarker 388 398	CBFβ‐MYH11
T46	Collection 223 289	FLT3‐ITD, TP53, RUNX1, ASXL1 aberrations, and KMT2A rearrangements
T48	Gene-Protein 709 712	AF9
T49	Gene-Protein 703 708	KMT2A
T50	Gene-Protein 717 723	DNMT3A
T51	Biomarker 703 712	KMT2A‐AF9
T52	Biomarker 768 782	RUNX1‐RUNXT1T1
T53	Gene-Protein 774 782	RUNXT1T1
T54	Gene-Protein 768 773	RUNX1
T55	Biomarker 784 794	CBFβ‐MYH11
T56	Gene-Protein 789 794	MYH11
T57	Gene-Protein 784 788	CBFβ
T58	Gene-Protein 810 815	CEBPA
T59	Gene-Protein 860 864	NRAS
T60	Gene-Protein 1520 1525	ASXL1
T61	Gene-Protein 1056 1061	RUNX1
T62	Gene-Protein 1039 1043	TET2
T63	Gene-Protein 1045 1050	ASXL1
T64	Gene-Protein 1243 1249	PTPN11
T65	Gene-Protein 1289 1293	TP53
T66	Gene-Protein 1271 1275	TET2
T67	Gene-Protein 1277 1283	DNMT3A
T68	Gene-Protein 1251 1255	NPM1
T69	Gene-Protein 1264 1269	ASXL1
T70	Gene-Protein 1257 1262	RUNX1
T71	Gene-Protein 1314 1317	WT1
T17	Gene-Protein 1512 1518	DNMT3A
T72	Gene-Protein 1531 1535	TET2
T73	Gene-Protein 1732 1736	FLT3
T74	Gene-Protein 1814 1819	ASXL1
T75	Gene-Protein 1824 1828	NRAS
T76	Gene-Protein 1353 1357	TP53
T77	Gene-Protein 1342 1348	DNMT3A
T78	Gene-Protein 1713 1717	NPM1
T13	Gene-Protein 899 904	MYH11
T15	Gene-Protein 866 872	DNMT3A
T31	Gene-Protein 874 878	IDH1
T79	Gene-Protein 1033 1037	TP53
T23	Gene-Protein 894 898	CBFβ
T33	Biomarker 1469 1554	epigenetic modifier genes (EMGs) including DNMT3A, ASXL1, and TET2 were more frequent
R16	Prognostic-Poor Arg1:T33 Arg2:T22	
T21	Disease 1614 1646	age‐related clonal hematopoiesis
#2	AnnotatorNotes T21	D000082182
#3	AnnotatorNotes T44	not found, not found
#4	AnnotatorNotes T12	not found
#5	AnnotatorNotes T14	not found
T80	Biomarker 1309 1327	less WT1 mutations
T81	Collection 1217 1327	more mutations concerning PTPN11, NPM1, RUNX1, ASXL1, TET2, DNMT3A, and TP53 genes, but had less WT1 mutations
R21	Association Arg1:T81 Arg2:T18	
R22	Prognostic-Poor Arg1:T20 Arg2:T18	
#6	AnnotatorNotes T24	not found
T82	Biomarker 1732 1740	FLT3‐ITD
T26	Collection 1708 1740	less NPM1 mutations and FLT3‐ITD
R23	Association Arg1:T26 Arg2:T24	
R24	Association Arg1:T30 Arg2:T27	
T86	Collection 349 398	biCEBPA mutations, RUNX1‐RUNXT1T1, and CBFβ‐MYH11
R2	Prognostic-Good Arg1:T86 Arg2:T2	
R1	Prognostic-Poor Arg1:T46 Arg2:T2	
T47	Biomarker 830 904	genetic aberrations including NRAS, DNMT3A, IDH1 mutations, and CBFβ‐MYH11
T87	Collection 954 968	e‐AML or s‐AML
R4	Association Arg1:T47 Arg2:T87	
T10	Collection 703 815	KMT2A‐AF9 and DNMT3A mutations and less favorable ones including RUNX1‐RUNXT1T1, CBFβ‐MYH11, and biallelic CEBPA
R5	Prognostic-Poor Arg1:T10 Arg2:T44	
#7	AnnotatorNotes T27	not found
